Haleon (LON:HLN) Stock Price Down 0.7% – What’s Next?

Haleon plc (LON:HLN)’s stock price dropped 0.7% during mid-day trading on Monday . The company traded as low as GBX 359.95 ($4.88) and last traded at GBX 360.70 ($4.89). Approximately 10,357,583 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 24,445,391 shares. The stock had previously closed at GBX 363.17 ($4.92).

Wall Street Analysts Forecast Growth

HLN has been the subject of a number of research analyst reports. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 370 target price on shares of Haleon in a research report on Thursday, July 31st. Berenberg Bank decreased their price objective on Haleon from GBX 503 to GBX 500 and set a “buy” rating for the company in a report on Friday, August 8th. Finally, JPMorgan Chase & Co. reissued an “underweight” rating on shares of Haleon in a report on Friday, August 1st. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of GBX 435.

Haleon Stock Performance

The company has a 50-day simple moving average of GBX 364.13 and a two-hundred day simple moving average of GBX 382.50. The company has a debt-to-equity ratio of 53.36, a quick ratio of 0.93 and a current ratio of 0.84. The firm has a market capitalization of £32.40 billion, a P/E ratio of 2,159.88, a PEG ratio of 1.49 and a beta of 0.19.

Haleon (LON:HLN) last released its quarterly earnings data on Thursday, July 31st. The company reported GBX 8.90 earnings per share (EPS) for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. As a group, equities analysts forecast that Haleon plc will post 19.5033282 EPS for the current year.

Insider Activity at Haleon

In other Haleon news, insider Dawn Allen sold 64,329 shares of the firm’s stock in a transaction dated Monday, June 30th. The stock was sold at an average price of GBX 376, for a total transaction of £241,877.04. 0.01% of the stock is owned by company insiders.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.